Skip to main content
logo
Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.69
-0.01 (-0.07%)
Jul 31, 2026, 4:08 PM HKT

HKG:1681 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,078910.46784.53682.91590.17
Depreciation & Amortization
66.5963.9978.0976.3672.99
Loss (Gain) From Sale of Assets
1.930.350.854.121.99
Loss (Gain) From Sale of Investments
-3.470.09-0.23--
Loss (Gain) on Equity Investments
1.60.07---
Stock-Based Compensation
----1.7823.41
Provision & Write-off of Bad Debts
-1.02-8.78-12.6-32.49-18.04
Other Operating Activities
-23.85-33.07-14.3339.93-90.34
Change in Accounts Receivable
-21.51-27.9-1.71113.87114.21
Change in Inventory
18.2777.41-89.69-54.9-39.56
Change in Accounts Payable
138.57116.9280.76114.4150.99
Change in Unearned Revenue
-1.94-4.55-0.462.261.67
Change in Other Net Operating Assets
-41.44-8.01-6.24318.04
Operating Cash Flow
1,2121,087818.97947.68725.54
Operating Cash Flow Growth
11.48%32.73%-13.58%30.62%-16.32%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-68.48-109-52.56-51.59-98.25
Sale of Property, Plant & Equipment
-0.330.151.20.32
Sale (Purchase) of Intangibles
-1,018----
Investment in Securities
-1,121-143.06-248.27-365.67-230
Other Investing Activities
54.0564.8268.9247.2629.62
Investing Cash Flow
-2,153-186.91-231.77-368.8-298.31

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
223.07497.55442.39259.32295.72
Long-Term Debt Repaid
-276.38-758.2-382.93-436.67-235.81
Net Debt Issued (Repaid)
-53.32-260.6559.46-177.3559.91
Issuance of Common Stock
16.03142.9914.22.6414.57
Repurchase of Common Stock
-168.02---29.07-30.15
Common Dividends Paid
-498.39-680.54-326.25-127.49-198.08
Other Financing Activities
-8.0468.94-27.51-10.93-12.91
Financing Cash Flow
-711.74-729.26-280.1-342.21-166.66

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-20.24-11.4-9.0117.18-4.52
Net Cash Flow
-1,673159.42298.09253.85256.05

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,143977.99766.41896.09627.29
Free Cash Flow Growth
16.91%27.61%-14.47%42.85%-23.35%
Free Cash Flow Margin
33.46%32.96%29.59%38.30%30.68%
Free Cash Flow Per Share
1.341.180.961.130.78
Levered Free Cash Flow
-208.28681.72507.99650.74464.15
Unlevered Free Cash Flow
-205.55697.28521.28657.57472.21

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4.3624.891.090.5612.91
Cash Income Tax Paid
34.337.1820.0313.21134.68
Change in Working Capital
91.94153.88-17.34178.64145.35